Methylprednisolone in Tanzania: NEMLIT level, who can prescribe it and STG references

Methylprednisolone is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level D (regional referral hospital). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.

Last updated

New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.

Is methylprednisolone available on the DukaDawa pharmacy network?

Not yet. Methylprednisolone is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.

Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.

Is methylprednisolone on the NEMLIT, and who can prescribe it?

Yes. Methylprednisolone is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level D (regional referral hospital). At level D it may be prescribed by specialists, medical officers and dental officers.

Level
D (regional referral hospital)
Category
Adrenal Hormones and Synthetic Substitutes (Hormones and Antihormones)
Listed forms
1000 mg powder and solvent for solution for injection/infusion; Tablet 4mg; 8mg;; Injection 40mg/mL
Page
NEMLIT, p. 15
Who may prescribe at each NEMLIT level (STG/NEMLIT 7th edition, Part I, Table 1). Levels listed for this medicine are highlighted.
LevelFacilityWho may prescribe
ADispensarySpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer
BHealth centreSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer
CCouncil or district hospitalSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer
D (listed)Regional referral hospitalSpecialist, Medical Officer, Dental Officer
SZonal, special and national hospitalsSpecialist

A medicine is listed from the lowest facility level where it should be available.

Where is methylprednisolone in the Standard Treatment Guidelines?

The Standard Treatment Guidelines (7th edition, 2026) mention methylprednisolone in 8 or more sections, most often section 21.4.2 Glomerular Diseases (GD) > Nephrotic syndrome (p. 541). See the STG for treatment details.

  • 21.4.2 Glomerular Diseases (GD) > Nephrotic syndrome, p. 541
  • 21.5.3.3 Kidney Transplantation > Transplant Recipient > Other Induction Medicines, p. 548
  • 21.5.4 Kidney Transplantation > Acute Kidney Graft Rejection, p. 550
  • 26.4.3 Managing Systemic Vasculitis > Small Vessel Vasculitis (SVV), p. 727
  • 1.11 Anaphylaxis, p. 42
  • 3.1.6 Anaemia > Aplastic Anaemia (Bone Marrow Failure), p. 77
  • 3.5 Hematopoietic Stem Cell Transplantation, p. 84
  • 8.2.3 Initial Management of Stroke > Initial management of Acute Ischemic Stroke, p. 178

Sections that mention Methylprednisolone, most mentions first. Positions only: see the STG for treatment details.

All adrenal hormones and synthetic substitutes on the NEMLIT

Sources

  • Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania

Page last updated

STG positions are section numbers and printed page numbers only.

This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.

For licensed prescribers and pharmacists. Not medical advice. Check the Standard Treatment Guidelines before prescribing.